Maria Cecilia Perrone
Overview
Explore the profile of Maria Cecilia Perrone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
25
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cascardo F, Vivanco M, Perrone M, Werbach A, Enrico D, Mando P, et al.
Sci Rep
. 2024 Oct;
14(1):25136.
PMID: 39448637
PI3K/AKT/mTOR pathway is implicated in breast cancer progression and recurrence. The identification of PIK3CA and AKT1 mutations and loss of PTEN serve as selection criterion for targeted therapies involving selective...
2.
Rodriguez M, Perrone M, Riggio M, Palafox M, Salinas V, Elia A, et al.
Sci Rep
. 2023 Feb;
13(1):2710.
PMID: 36792625
Resistance to therapy remains a major obstacle in cancer management. Although treatment with hormone and CDK4/6 inhibitors is successful in luminal breast cancer, resistance to these treatments is frequent, highlighting...
3.
Polo M, Riggio M, May M, Rodriguez M, Perrone M, Stallings-Mann M, et al.
Oncotarget
. 2015 Jun;
6(26):22081-97.
PMID: 26098779
Improved efficacy of neoadjuvant endocrine-targeting therapies in luminal breast carcinomas could be achieved with optimal use of pathway targeting agents. In a mouse model of ductal breast carcinoma we identify...